Literature DB >> 22290542

Thrombotic microangiopathy: rituximab in severe autoimmune TTP.

Rebecca Ireland.   

Abstract

Entities:  

Year:  2012        PMID： 22290542     DOI： 10.1038/nrneph.2012.7

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.

Authors:  Antoine Froissart; Marc Buffet; Agnès Veyradier; Pascale Poullin; François Provôt; Sandrine Malot; Michael Schwarzinger; Lionel Galicier; Philippe Vanhille; Jean-Paul Vernant; Dominique Bordessoule; Bertrand Guidet; Elie Azoulay; Eric Mariotte; Eric Rondeau; Jean-Paul Mira; Alain Wynckel; Karine Clabault; Gabriel Choukroun; Claire Presne; Jacques Pourrat; Mohamed Hamidou; Paul Coppo
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598
  1 in total
  1 in total

1.  Effectiveness of Intravenous Immunoglobulin Plus Plasmapheresis on Antibody-mediated Rejection or Thrombotic Microangiopathy in Iranian Kidney Transplant Recipient.

Authors:  Simin Dashti-Khavidaki; Lida Shojaie; Amin Hosni; Mohammad Reza Khatami; Atefeh Jafari
Journal:  Nephrourol Mon       Date:  2015-05-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.